User: TahirAmin Topic: IP
Category: patents :: india
Last updated: May 21 2018 20:03 IST RSS 2.0
 
1 to 20 of 14,779    
Maximaa Systems forays into Herbal / Ayurvedic Formulations 21.5.2018 General News
Launches 'Proyurveda' range of products
Also found in: [+]
MPI to supply animal tissues to SCTIMST 19.5.2018 Hindu: Thiruvananthapuram
Sree Chitra Tirunal Institute for Medical Sciences and Technology has entered into an agreement with the Meat Products of India (MPI), wherein the la
Also found in: [+]
Fresh and natural, in a bottle 18.5.2018 Hindu: Home
This sugarcane juice has a longer shelf life, needs no refrigeration and is free of preservatives
Also found in: [+]
Trinity League India standalone net profit rises 293.75% in the March 2018 quarter 17.5.2018 General News
Sales rise 440.00% to Rs 0.81 crore
Also found in: [+]
Ayushman Bharat may help patients access life-saving drugs 16.5.2018 Rediff: Top Stories (India)
'We have often heard the mythical argument that patents block access to life-saving drugs, but only 5% of medicines from multinational companies are under patent protection in India.''Where these patented products are beyond the reach of Indian patients, the companies have programmes to facilitate access to their drugs, for free or for a fraction of the price,' points out Ranjana Smetacek, former director general, Organisation of Pharmaceutical Producers of India.
Also found in: [+]
ITAT says Google India should pay tax on advt revenue sent to parent 15.5.2018 General News
In a setback to Google India, the Income Tax Appellate Tribunal has upheld a tax demand on the search engine's remittances of advertisement revenue to Google Ireland Ltd. The Bangalore bench of ITAT, in a 331-page order, upheld the tax department's contention that such payments are royalty and therefore subject to withholding tax. Google India said it will challenge the ruling in the High Court. The company had filed an appeal in the ITAT against "characterization of the payment made by it to Google Ireland Ltd in respect of the purchase of advertisement space for resale to the advertisers in India under the Google AdWords programme distribution agreements". For the assessment year 2012-13, the tax department had found Rs 1,114.91 crore to have been credited to Google Ireland Ltd (GIL) without deduction of tax at source. And so, it issued a tax demand of Rs 258.84 crore. In its submissions, Google India Ltd said it was a mere non-exclusive distributor/reseller of AdWords programme to .
Also found in: [+]
Coolpad sues Xiaomi for patent violation 14.5.2018 Sify Finance
After media reports surfaced last week that Chinese smartphone makers Xiaomi and Coolpad have locked horns over patents, the latter on Monday confirmed that it has sued three group firms of Xiaomi for several patent infringements.
Also found in: [+]
Coolpad sues Xiaomi for patent violation 14.5.2018 General News
After media reports surfaced last week that Chinese smartphone makers Xiaomi and Coolpad have locked horns over patents, the latter on Monday confirmed that it has sued three group firms of Xiaomi for several patent infringements.
Also found in: [+]
Reward innovation 12.5.2018 Hindu: Internet
A robust intellectual property rights (IPR) framework, with suitable enforcement systems, is critical to support India’s efforts to be a global leade
Also found in: [+]
Bharat Biotech receives National Technology Award for Rotavac 11.5.2018 All News-IANS Stories
Leading vaccine maker Bharat Biotech on Friday received the National Technology Award for 2018 from the Central government's Technology Development Board for its Rotavac vaccine.
Also found in: [+]
Pfizer, FITT announce Call for proposals under PIDIIP 10.5.2018 General News
The Pfizer IIT Delhi Innovation and IP Program (PIDIIP) envisages a unique partnership model is designed to provide funding, resources, expertise and infrastructure to propel India's healthcare innovations from idea to intellectual property (IP).The program envisages active support for incubation and intellectual property creation.There are two components of the Pfizer IIT Delhi Innovation & IP Program (PIDIIP):For innovators seeking comprehensive support to translate their healthcare ideas into new business opportunities, the Program provides:-Incubation at IIT Delhi's incubators for a period of up to two years.-Funding of up to Rs 50 lakhs for each innovator/start-up to take ideas through proof of concept to IP-Mentoring support from IIT Delhi's faculty and FITT nominated experts.-IP search and filing services.-Guidance from Pfizer's experts.For innovators who already have a proof of principle/concept and are only looking for IP related support, the program provides:-Access to ..
Also found in: [+]
Armstrong Pame named among 100 of world's brightest under 40 10.5.2018 Manipur: E-Pao
Armstrong Pame named among 100 of world's brightest under 40
Also found in: [+]
'Indian IP and liabilities law barrier to pharma R&D investment' 10.5.2018 General News
India's intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that prevents them from increasing their footprint in the country's huge market, pharma sector leaders have said. Andrew Plump, chief medical and scientific officer of Takeda Pharmaceuticals, a major Japanese drugmaker, said his company has a very limited presence in India. "But it is open to increase its footprint in India, with the improvement in IP protection laws and those related to liabilities," Plump said. "I think more and more there's an intent in India to try to open up its doors. I think if that happens, and if it facilitates entry of innovative patent protected pharmaceuticals you will see value driven companies coming into India," Plump told PTI on the sidelines of the 12th annual biopharma and healthcare summit here. "Historically it (IP sector regulations and liabilities law) has been not just a hindrance but a barrier and impediment (for the .
Also found in: [+]
Ensure software standards don't create monopolies: Ravi Shankar Prasad tells IT cos 8.5.2018 DNA: Urban Tales
Law and IT minister Ravi Shankar Prasad today cautioned software companies that norms or standards being worked out by the industry should not create monopolies in the market and instead facilitate digital inclusion and innovation. "Standards .. Should be nuanced in a manner that the ability of standards should not become monopoly of few and exclusion of others. Why I am saying so because open source of software was area of great debate even from international players too. On the garb of close source I would not allow India to become monopoly of few," Prasad said. He was speaking at an event by CNBC-TV18 and The Bureau of Indian Standards (BIS) on standard for softwares. Earlier some of the global firms have attempted that software coding should be granted patents but the same had been opposed by various Indian companies and not-profit entities. "Standard must lay down standard of compliance, standard must lay down to facilitate operation, standard to ensure cost effective operation. Standard should also ...
Also found in: [+]
Prabhu urges pharma firms to do more R&D, develop new markets 8.5.2018 All News-IANS Stories
Indian pharmaceutical companies need to increase R&D investments and develop new markets in order to boost their exports, Commerce Minister Suresh Prabhu said on Tuesday.
Also found in: [+]
Hyderabad varsity students get patent for water purifying 8.5.2018 General News
A team of faculty and research scholars of the University of Hyderabad (UoH) has got a patent for having developed a water purifying agent. Scientists at the varsity developed nanometric silver particle-embedded polymer thin films with wide applications, including anti-bactericidal action, a press release from the varsity said. The team developed the simple and economically viable methodology for purifying drinking water, it said. The group had obtained the patent on April 26 from Patent Office, Government of India. Also, the agent can be used repeatedly, allowing simultaneously its monitoring using spectroscopy and microscopy, the release added.
Also found in: [+]
GM cotton patent row: SC notice on Monsanto's plea 7.5.2018 All News-IANS Stories
The Supreme Court on Monday asked an Indian company to respond to Monsanto's plea challenging a Delhi High Court verdict holding that the American firm cannot claim a patent on its genetically modified (GM) cotton seeds.
Also found in: [+]
Supreme Court refuses to stay order against Monsanto on GM cotton patents 7.5.2018 General News
MUMBAI (Reuters) - The Supreme Court on Monday refused to grant a stay on a Delhi High Court ruling that U.S. company Monsanto cannot claim patents on its GM cotton seeds, but the world's largest seed maker said it is "confident on the merits" of its case.
Also found in: [+]
Flood of trademark applications from China alarms US officials 6.5.2018 Latest News
Having a trademark registered in the US is crucial for sellers on Amazon, whose brand-registry program rewards officially trademarked products with more site visibility and a higher listing in search
Also found in: [+]
India and emerging markets' 'innovation paradox': Technology-shy firms 5.5.2018 Business Standard: News Now
The country will need to create an environment where firms not only see the benefit of investing in innovation but also have the capability to do so
Also found in: [+]
1 to 20 of 14,779